QUARTERLY FOCUS ISSUE: HEART FAILURE: STATE-OF-THE-ART PAPER
Mitral Valve Surgery in Advanced Heart Failure
Thomas G. Di Salvo, MD, MPH, MBA*,*,
Michael A. Acker, MD ,
G. William Dec, MD and
John G. Byrne, MD*
* Vanderbilt University, Nashville, Tennessee
University of Pennsylvania, Philadelphia, Pennsylvania
Massachusetts General Hospital, Boston, Massachusetts
Manuscript received February 27, 2009;
revised manuscript received August 7, 2009,
accepted August 10, 2009.
* Reprint requests and correspondence: Dr. Thomas G. Di Salvo, Vanderbilt Heart and Vascular Institute, 1215 21st Avenue, MCE 5th Floor, Suite 5037, Nashville, Tennessee 37232 (Email: thomas.g.disalvo{at}vanderbilt.edu).
The appropriateness and timing of mitral valve surgery in patients with advanced heart failure and severe mitral regurgitation remains controversial. Recent surgical results provide evidence for beneficial effects on left ventricular remodeling and functional capacity. Given the absence of randomized trials comparing the outcomes of mitral valve surgery to medical therapy, however, clinical decision making regarding surgery for these fragile patients poses a dilemma to thoughtful clinicians. This paper reviews the pathophysiology of mitral regurgitation in heart failure and proposes an integrated approach to management.
Key Words: mitral regurgitation heart failure cardiac surgery
|
Abbreviations and Acronyms
| | CABG = coronary artery bypass graft surgery | | CRT = cardiac resynchronization therapy | | HF = heart failure | | LV = left ventricular | | LVEDD = left ventricular end-diastolic diameter | | LVEF = left ventricular ejection fraction | | MR = mitral regurgitation | | MRI = magnetic resonance imaging | | MV = mitral valve | | MVA = mitral valve annuloplasty | | MVR = mitral valve repair | | NHBLI = National Heart, Lung, and Blood Institute | | NYHA = New York Heart Association |
|
Related Article
-
Inside This Issue
J. Am. Coll. Cardiol. 2010 55: A35-A33.
[Full Text]
[PDF]
|